TrialHaematologica2024
Use, variability, and justification of eligibility criteria for phase II and III clinical trials in acute leukemia.
Andrew Hantel et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
10 papers cite it
this papercites it